RPL39P3

Across TCGA pan-cancer cohorts, RPL39P3 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RPL39P3’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL39P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL39P3 is over-expressed in tumor.

KIRC, COAD, and LIHC are the cancer types where RPL39P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL39P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.966	<.001	10	view →
COAD	All	All	+0.823	<.001	8	view →
LIHC	All	II,III,IV	+0.898	<.001	7	view →
KIRP	All	IV	+0.730	.022	4	view →
CHOL	All	All	+2.042	<.001	3	view →
PRAD	All	All	+0.600	.002	2	view →
LUSC	All	All	+0.385	.031	2	view →
LUAD	All	All	+0.688	.007	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RPL39P3–KIRC

Open the KIRC breakdown →